Knight Capital Group’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Knight Capital Group’s Portfolio OPTR Stock Details OPTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$179K	Buy	+12,415	New	+$181K	﹤0.01%	2756

Other funds holding OPTR

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Knight Capital Group's OPTR Position: Q2 2013 in Review

Knight Capital Group opened a new position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q2 2013: 12,415 shares worth $179K. The stake represents ﹤0.01% of the portfolio and ranks #2756 among its holdings.

103 funds tracked by Wall St. Rank hold OPTR as of Q2 2013.

Knight Capital Group held 12,415 shares of OPTIMER PHARMACEUTICALS, INC. COM STK worth $179K as of Q2 2013.
OPTIMER PHARMACEUTICALS, INC. COM STK was a new Knight Capital Group position in Q2 2013.
OPTIMER PHARMACEUTICALS, INC. COM STK made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2756 holding.
103 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.